Talabostat Completed Phase 2 Trials for Lung Cancers Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00080080Study of Talabostat and Docetaxel in Advanced Non-Small Cell Lung Cancer